A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V2)

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

November 27, 2023

Primary Completion Date

March 17, 2026

Study Completion Date

March 16, 2027

Conditions
NonSegmental Vitiligo
Interventions
DRUG

Povorcitinib

Oral, Tablet

DRUG

Placebo

Oral, Tablet

Trial Locations (86)

10065

Weill Cornell Medical College, New York

10117

Charite Universitaetsmedizin Berlin - Campus Charite Mitte, Berlin

13500

Cabinet Medical- Chemin de Paradis, Martigues

15831

Dermatologische Gemeinschaftspraxis, Mahlow

20089

Irccs Istituto Clinico Humanitas, Rozzano

20122

Fondazione Irccs Ca Granda Ospedale Maggiore, Milan

20246

Universitaetsklinikum Hamburg-Eppendorf, Hamburg

20769

Callender Dermatology and Cosmetic Center, Glenn Dale

20850

Aesthetic and Dermatology Center, Rockville

25123

Asst Degli Spedali Civili Di Brescia, Brescia

29200

Chru Morvan/Chu Brest Hopital Morvan, Brest

30068

Dermatology and Surgery Specialists of North Atlanta, Marietta

30328

Advanced Medical Research Pc, Sandy Springs

33134

Driven Research Llc, Coral Gables

Florida Academic Centers Research and Education Llc, Coral Gables

33146

Pediatric Skin Research Llc, Coral Gables

33401

Metabolic Research Institute Inc, West Palm Beach

33437

Total Vein and Skin Llc, Boynton Beach

33486

Skin Care Research, Llc, Boca Raton

36117

C2 Research Center, Llc, Montgomery

43215

Remington-Davis Clinical Research, Columbus

48149

Universitaetsklinikum Muenster, Münster

48202

Henry Ford Health System, Detroit

60118

Dundee Dermatology, West Dundee

70809

Delricht Research, Baton Rouge

72037

Centre Hospitalier - Le Mans, Le Mans

75024

Innovative Dermatology: Legacy Medical Village, Plano

75230

Dermatology Treatment and Research Center, Dallas

76031

Hopital Charles Nicolle, Rouen

77008

Heights Dermatology and Aesthetic Center, Houston

77030

University of Texas, Md Anderson Cancer, Houston

78218

Texas Dermatology and Laser Specialists, San Antonio

78229

Dermatology Clinical Research Center of San Antonio, San Antonio

90045

Dermatology Research Associates, Los Angeles

91320

Clinical Trials Research Institute, Thousand Oaks

92647

Marvel Clinical Research Llc, Huntington Beach

94538

Center For Dermatology Clinical Research, Inc, Fremont

95123

Azienda Policlinico Vittorio Emanuele, Catania

97223

Oregon Medical Research Center, Pc, Portland

99202

Premier Clinical Research, Spokane

481455

Fachklinik Bad Bentheim, Bad Bentheim

35294-0007

University of Alabama At Birmingham Hospital-Whitaker Clinic, Birmingham

92708-3701

First Oc Dermatology Research Inc, Fountain Valley

90036-5609

Vitiligo & Pigmentation Institute of Southern California, Los Angeles

46202-3082

Indiana University School of Medicine Iusm Indianapolis, Indianapolis

03801

Allcutis Research, Llc, Portsmouth

02600

Medical Center Asklepii Ood, Dupnitsa

05308

Medical Center Unimed Eood, Sliven

01407

Ambulatory For Specialized Medical Care - Individual Practice For Specialized Medical Care - Skin An, Sofia

01431

Aleksandrovska University Hospital, Sofia

01528

28 Diagnostic and Consultative Center, Sofia

V5Z 4E8

British Columbia'S Centre For Dermatologic Science - the Skin Care Centre, Vancouver

L3P 1X2

Lynderm Research Inc, Markham

L4Y 4C5

DERMEDGE, Mississauga

M3H 5Y8

Toronto Research Centre, Toronto

M4W 2N4

Research Toronto, Toronto

G1V4X7

Centre de Recherche Dermatologique de Quebec, Québec

06200

Centre Hospitalier Universitaire de Nice,Hopital L Archet, Nice

01307

University Hospital Carl Gustav Carus, Dresden

04027

Orvostudomanyi Kutato Es Fejleszto Kft, Debrecen

04032

Debreceni Egyetem, Debrecen

Unknown

Markusovszky Teaching Hospital, Szombathely

00168

Fondazione Policlinico Universitario Agostino Gemelli Irccs, Rome

80-382

Synexus Polska Sp. Z O.O. Oddzial W Gdansku, Gdansk

81-537

Synexus Gdynia, Gdynia

40-611

Provita Sp.Zo.O. Centrum Medyczne Angelius, Katowice

40-648

Pro Familia Altera Sp. Z O.O., Katowice

25-316

Prywatny Gabinet Dermatologiczny Elzbieta Klujszo, Kielce

90-265

Niepubliczny Zaklad Opieki Zdrowotnej Dermed Centrum Medyczne Sp. Z O.O., Lodz

90-436

Dermoklinika Centrum Medyczne S.C., M. Kierstan, J. Narbutt, A. Lesiak, Lodz

96-100

Velocity Clinical Research, Skierniewice, Skierniewice

70-332

Laser Clinic, Szczecin

71-434

Twoja Przychodnia - Szczecinskie Centrum Medyczne, Szczecin

33-100

Alergo-Med Specjalistyczna Przychodnia Lekarska Sp. Z O.O., Tarnów

02-625

Centrum Medyczne Evimed, Warsaw

02-692

Royalderm Agnieszka Nawrocka, Warsaw

02-953

Klinika Ambroziak Sp. Z O.O., Warsaw

03-291

Futuremeds Targowek Centrum Medyczne Amed Warszawa Targowek, Wrocaw

50-088

Synexus Polska Sp. Z O.O. Oddzial We Wroclawiu, Wroclaw

51-318

Dermmedica Sp. Z O.O., Wroclaw

52-416

Centrum Medyczne Oporow, Wroclaw

IP4 5PD

Ipswich Hospital, East Suffolk and North Essex Nhs Foundation Trust, Ipswich

LE1 5WW

University Hospitals of Leicester-Leicester Royal Infirmary (Lri), Leicester

E11 1NR

Whipps Cross University Hospital - Barts Health Nhs Trust, London

NG7 2FT

Nottingham University Hospitals - Treatment Center, Nottingham

WS2 9PS

Royal Wolverhampton Nhs Trust, Walsall

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Incyte Corporation

INDUSTRY

NCT06113471 - A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V2) | Biotech Hunter | Biotech Hunter